Completed Bones, Joints & Muscles Engineering

A Centre for Medical Engineering Solutions in the Management of Osteoarthritis.

In plain English

AI plain-English summary

Osteoarthritis patients face a future of joint replacement surgery because doctors lack reliable tools to catch the disease early and track its progression. The problem is that osteoarthritis—a degenerative joint condition affecting millions—is typically diagnosed only after significant damage has occurred. Current treatments focus on managing pain rather than halting the disease. This Centre at Imperial College aims to change that by bringing engineers, clinicians, and fundamental scientists together to develop a suite of technologies that address the entire patient journey, from diagnosis through surgery to rehabilitation. If successful, the Centre could deliver an aptamer-based blood test that detects osteoarthritis biomarkers years before symptoms appear, allowing earlier intervention. It would also produce tissue-engineered cartilage implants that integrate with natural bone, next-generation joint replacements that last longer, and surgical tools for minimally invasive procedures. Better biomechanical understanding of diseased knees could improve rehabilitation protocols, helping patients recover function after surgery. Seven of the applicants already have spin-out company experience, so the technologies are designed for commercial translation into products that improve healthcare delivery.

View original technical description
We will create a Centre at Imperial College that brings together a critical mass of engineers, clinicians and basic scientists, collaborating to use technology to improve the diagnosis, understanding, surgical management and rehabilitative treatment of osteoarthritis. The Centre will build on substantial existing infrastructure and leverage our world leading technologies to achieve the following key goals: - Develop an aptamer based platform technology for detection of known and emerging biomarkers for osteoarthritis, permitting better diagnosis and longitudinal monitoring of patients. - Create techniques for growing tissue engineered osteochondral constructs with superior mechanical and integrative properties. - Engineer next generation implants for joint replacement surgery. - Develop hardware, software and expertise for more accurate surgical treatments of joint disease, including minimally invasive surgical approaches. - Improve fundamental understanding of the cellular and molecular mechanisms of osteoarthritis, thus identifying next generation therapeutic targets. - Characterise the biomechanics of normal and diseased knees. - Deliver technologies which improve patient compliance and outcomes during rehabilitation. The proven technology transfer track record of the applicants, seven of whom are already involved with spin out companies, plus Imperial College's ethos of technology development and commercialization, will ensure that the innovations developed by the Centre will be translated into products that improve healthcare delivery.

View the original record at the funder ↗

Researchers

Ethier (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Enabling Individualised Surgical Treatment of Osteoarthritis
Centre for osteoarthritis pathogenesis Versus Arthritis
Additive manufacturing of advanced medical devices for cartilage regeneration: minimally invasive early intervention
International Centre of Excellence in the Treatment of Pathological Fractures
Optimising knee therapies through improved population stratification and precision of the intervention

Original classification

Programme Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.